Schiff Guides Deep Medicine Acquisition Corp. in Upsized $126.5M SPAC IPO

Schiff Hardin LLP served as underwriter’s counsel for Deep Medicine Acquisition Corp.’s upsized initial public offering raising gross proceeds of $126.5 million.

Schiff Hardin LLP served as underwriter’s counsel for Deep Medicine Acquisition Corp.’s upsized initial public offering raising gross proceeds of $126.5 million.

I-Bankers Securities, Inc. acted as sole book-running manager of the offering, which closed on Oct. 29, 2021.

Deep Medicine Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company intends to focus its search on targets in the healthcare industry with an enterprise value of approximately $500 million to $1 billion.

Smart In Your World
Your goals define our mission. Whether an immediate need or a long-term objective, ArentFox Schiff helps you reach your full potential. As industry insiders, we partner with you to develop practical business strategies and sophisticated legal solutions to achieve today’s targets and anticipate tomorrow’s problems. We get you across the finish line.

Contacts

Continue Reading